Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article

Emergence of Omicron sub-variant BA.2: Is it a matter of concern amid the COVID-19 pandemic?

“…Therefore, scientists were concerned about the larger frequency of mutations in the Omicron variant. Higher transmissibility, decreased vaccination effectiveness, and an increased risk of reinfection are issues related to new variants of SARS-CoV-2 [ 2 ], which the scientific communities have raised over the last few months [ [1] , [2] , [3] ].…”

Monkeypox: An extra burden on global health

“…Since emergence of the COVID-19 pandemic, caused by the SARS-COV-2 in late December 2019, a few new threats developed chief of which are novel variants of COVID-19 [ 1 , 2 ] that have a potential immune escape. In addition, the Russo-Ukraine war, acute severe hepatitis in children of unknown origin and, recently, monkeypox virus in non-endemic areas like Europe and Latin America which further affects the social, mental, and economic status globally.…”

Deltacron: Apprehending a new phase of the COVID-19 pandemic

“…Variants of interest (VOIs) and variants of concern (VOCs), both of which exhibit a mutation pattern, have been identified as a contagious threat to global public health [ 1 , 2 ]. Some of these variants expanded to become pandemics [ 3 ], while others stayed epidemic in a limited geographic region (World Health Organization, https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ ). Up to now, five VOCs have been reported: Alpha (lineage B.1.1.7), Beta (lineage B.1.351), Gamma (lineage P.1), Delta (lineage B.1.617.2), and Omicron (lineage B.1.1.529), as well as eight VOIs including Lambda (C.37) and Mu (B.1.621) [ 1 , 2 ].…”